Your browser doesn't support javascript.
loading
Efficacy of a Rhealba® Oat Extract-based emollient on chronic pruritus in elderly French outpatients.
Theunis, J; Chaussade, H; Bourgeois, O; Mengeaud, V.
Afiliação
  • Theunis J; Skin Research Center, Pierre Fabre Dermo-Cosmétique, Toulouse, France.
  • Chaussade H; Private Practice, Saint-Orens de Gameville, France.
  • Bourgeois O; Private Practice, Saint-Orens de Gameville, France.
  • Mengeaud V; Skin Research Center, Pierre Fabre Dermo-Cosmétique, Toulouse, France.
J Eur Acad Dermatol Venereol ; 31 Suppl 1: 1-7, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28120350
ABSTRACT

BACKGROUND:

Chronic pruritus, defined as itch persisting more than 6 weeks, is a debilitating problem that affects one in four elderly adults. Emollients are recommended for the management of pruritus, but evidence of efficacy is scarce.

OBJECTIVE:

Assess the efficacy of a Rhealba® Oat Extract-based emollient in the management of chronic pruritus in elderly outpatients.

METHODS:

This was a randomized, mono-centric, open-label, cross-over study in adults ≥60 years of age with xerosis associated with chronic pruritus. Subjects were randomized 11 to start with a 2-week non-treatment phase or a 2-week treatment phase in which they applied the emollient once or twice daily. The primary outcome was subject-assessed pruritus using an established visual analogue scale. Subjects also assessed pruritus using the 5-D itch scale. Investigators assessed xerosis using the Overall Dry Skin Score and measured hydration index by Corneometer® , desquamation by D-Squame and transepidermal water loss by Aquaflux® .

RESULTS:

Thirty subjects were included. Pruritus intensity on the visual analogue scale improved significantly more during the treatment phase than during the non-treatment phase (P < 0.0001). This was also observed immediately after the first product application (P < 0.0001). According to the 5-D itch scale, pruritus decreased during the treatment phase but remained stable during the non-treatment phase (P = 0.0042). At the end of the treatment phase, more than half of the subjects reported an improvement in pruritus, and 30% reported complete disappearance, whereas pruritus remained stable during the non-treatment phase (P < 0.0001). Xerosis improved significantly more during the treatment phase than during the non-treatment phase as measured by D-Squame, clinical assessment and hydration index (P < 0.0001). Transepidermal water loss did not significantly change.

CONCLUSION:

Daily use of a Rhealba Oat Extract-based emollient can provide relief to elderly adults who suffer from xerosis associated with chronic pruritus.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prurido / Emolientes Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prurido / Emolientes Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article